To examine the effect of BCL11B expression in HCC tumor cells on the prognosis of the reported cases, the PFS and OS were assessed in BCL11B‐positive (>5% positive in IHC analyses, n = 67) and BCL11B‐negative (n = 98) groups. This evidence concerns the gene BCL11B and neoplasm.